Foghorn Therapeutics, Inc. (FHTX)
1.89
+0.04
(+2.16%)
USD |
NASDAQ |
Oct 19, 15:46
Foghorn Therapeutics EPS Diluted (Quarterly) : -0.1018 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1018 |
| March 31, 2026 | -0.2858 |
| December 31, 2025 | -0.3824 |
| September 30, 2025 | -0.2514 |
| June 30, 2025 | -0.2848 |
| March 31, 2025 | -0.2997 |
| December 31, 2024 | -0.3508 |
| September 30, 2024 | -0.3054 |
| June 30, 2024 | -0.4455 |
| March 31, 2024 | -0.5896 |
| December 31, 2023 | -0.5701 |
| September 30, 2023 | -0.3413 |
| June 30, 2023 | -0.705 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.7292 |
| December 31, 2022 | -0.691 |
| September 30, 2022 | -0.6184 |
| June 30, 2022 | -0.6579 |
| March 31, 2022 | -0.6506 |
| December 31, 2021 | -0.7687 |
| September 30, 2021 | -0.7054 |
| June 30, 2021 | -0.6272 |
| March 31, 2021 | -0.6243 |
| December 31, 2020 | -0.5642 |
| September 30, 2020 | -0.5128 |
| June 30, 2020 | -2.902 |
| March 31, 2020 | -2.707 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.191M |
| Revenue (Quarterly) | 16.07M |
| Total Expenses (Quarterly) | 23.26M |
| Enterprise Value | -15.86M |
| Gross Profit Margin (Quarterly) | 98.76% |
| Profit Margin (Quarterly) | -44.74% |
| Earnings Yield | -54.04% |
| Normalized Earnings Yield | -50.18 |